Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Scorpius Holdings Inc SCPX

Healthcare Biotechnology
Scorpius Holdings, Inc., formerly NightHawk Biosciences, Inc., is an integrated contract development and manufacturing company. The Company is focused on advancing biologic and cell therapy programs to the clinic and beyond. It offers a broad array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its facilities in San Antonio... see more

Recent & Breaking News (NYSEAM:SCPX)

Heat Biologic's COVID-19 Vaccine Demonstrates Robust T Cell Driven Immune Response to SARS-CoV-2 in Preclinical Studies

Accesswire August 13, 2020

Heat Biologics Provides Second Quarter 2020 Business Update

Accesswire August 7, 2020

Heat Biologics Highlights Importance of T cell Immunity to Prevent COVID-19

Accesswire August 5, 2020

Heat Biologics COVID-19 Vaccine Demonstrates Immunogenicity Proof-of-Concept in Pre-Clinical Studies

Accesswire July 29, 2020

Heat Biologics Regains Compliance with Nasdaq Minimum Bid Price Rule

Accesswire July 27, 2020

Heat Biologics Announces First Patient Treated in First-in-Human Clinical Trial of PTX-35

Accesswire June 22, 2020

Heat Biologics Announces Initiation of the Lead Clinical Trial Site for PTX-35

Accesswire June 18, 2020

Heat Biologics Announces FDA Clearance of Investigational New Drug (IND) Application for PTX-35

Accesswire June 8, 2020

Heat Biologics Provides Update on COVID-19 Vaccine Efforts

Accesswire June 4, 2020

Heat Biologics Presents Positive Survival Benefit for HS-110 in Combination with Nivolumab in Phase 2 Lung Cancer Trial at 2020 American Society of Clinical Oncology (ASCO) Annual Meeting

Accesswire May 29, 2020

Heat Biologics Announces Collaboration with Waisman Biomanufacturing to Manufacture COVID-19 Vaccine

Accesswire May 27, 2020

Heat Biologics Provides First Quarter 2020 Business Update

Accesswire May 15, 2020

Positive Survival Data from Phase 2 Lung Cancer Trial Accepted for Presentation at 2020 American Society of Clinical Oncology (ASCO) Annual Meeting

Accesswire May 14, 2020

Heat Biologics Provides Clinical Update; Reports Continued Progress Advancing HS-110

Accesswire May 11, 2020

Heat Biologics Reports Progress on COVID-19 Efforts and Timeline of Anticipated Q2 2020 Milestones

Accesswire April 29, 2020

Heat Biologics Announces Formation of COVID-19 Advisory Board

Accesswire April 1, 2020

Heat Biologics Provides Year-End Business Update

Accesswire March 30, 2020

Heat Biologics and University of Miami Developing Proprietary COVID-19 Diagnostic Test Under Collaborative Research Agreement

Accesswire March 23, 2020

Heat Biologics Invited to Join The Alliance for Biosecurity

Accesswire March 16, 2020

Heat Biologics, Inc. to Present at the Spring Investor Summit on March 25th-26th in New York City

Accesswire March 5, 2020